HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

3- (3,4- difluorophenyl)- 4- (4- (methylsulfonyl)phenyl)- 2(5H)- furanone

structure given in first source
Also Known As:
3-(3,4-difluorophenyl)4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone; MF tricyclic; MF-tricyclic; Merck Frosst Tricyclic
Networked: 13 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Clark, Patsy: 2 articles (05/2008 - 04/2007)
2. Xu, Daigen: 2 articles (05/2008 - 04/2007)
3. Audoly, Laurent: 2 articles (05/2008 - 04/2007)
4. Rowland, Steven E: 2 articles (05/2008 - 04/2007)
5. Lanas, Angel: 1 article (09/2012)
6. Santander, Sonia: 1 article (09/2012)
7. Ortego, Javier: 1 article (09/2012)
8. Piazuelo, Elena: 1 article (09/2012)
9. Escartín, Alfredo: 1 article (09/2012)
10. Morandeira, Antonio: 1 article (09/2012)

Related Diseases

1. Polyps
2. Edema
3. Arthritis (Polyarthritis)
4. Neoplasms (Cancer)
5. Inflammation

Related Drugs and Biologics

1. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
2. Prostaglandins E (PGE)
3. Carrageenan
4. Sulindac (Copal)
5. Cyclooxygenase 2 (Cyclooxygenase-2)
6. Indomethacin (Indometacin)
7. Losartan (Cozaar)
8. Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
9. Lovastatin (Mevacor)
10. Apolipoproteins